Unlike the ACPA‐positive RA patients and the controls, the distribution of ACPA‐negative RA overlapped with the other three groups, indicating that the autoantibody profiles in ACPA‐negative RA were heterogeneous and different from ACPA‐positive RA. This evidence concerns the gene PRTN3 and rheumatoid arthritis.